Efficacy of Platelet-Rich Plasma Versus Mesotherapy with Recombinant Growth Factors and Stem Cell-Conditioned Media in Androgenetic Alopecia: A Retrospective Study

Overview

Journal Skin Appendage Disord

Specialty Dermatology

Date 2024 Oct 10

PMID 39386300

Authors

Athanasios J Stefanis

Petr Arenberger

Monika Arenbergerova

Dimitrios Rigopoulos

Affiliations

Soon will be listed here.

Abstract

Introduction: Androgenetic alopecia (AGA) is the most common type of hair loss. Platelet-rich plasma (PRP) and mesotherapy (MZT) injections of various solutions fortified with growth factors are popular treatment options for AGA. The aim of this study was to compare the efficacy of RPP and MZT products in the treatment of AGA.

Methods: This retrospective study included 72 AGA patients treated with two PRP formulations and two MZT products, administered manually or with a gun injector. Hair parameters (hair thickness, hair density, and hair count) on frontal and vertex areas were measured before and after 6 months.

Results: Over 6 months, trichoscopic parameters showed significant intragroup and intergroup variability. MZT1 and PRP2 groups exhibited statistically significant improvement in most parameters, while MZT2 significantly increased vertex hair density. Hair thickness changes differed significantly between PRP1 and PRP2 groups (unadjusted value <0.001) and possibly between MZT1 and PRP1 groups (unadjusted value = 0.049) in both regions.

Discussion: Injections of PRP and MZT formulations can significantly enhance trichoscopic parameters in AGA patients within a 6-month period, but the extent of improvement varies among different PRP and MZT products.

References

Li C, Pan L, Yang L, Kong J, Zhang L . An umbrella review of the use of platelet-rich plasma in the treatment of androgenetic alopecia. J Cosmet Dermatol. 2023; 22(5):1463-1476. DOI: 10.1111/jocd.15617. View

Stefanis A, Groh T, Arenbergerova M, Arenberger P, Bauer P . Stromal Vascular Fraction and its Role in the Management of Alopecia: A Review. J Clin Aesthet Dermatol. 2020; 12(11):35-44. PMC: 6937163. View

Fukuoka H, Suga H . Hair Regeneration Treatment Using Adipose-Derived Stem Cell Conditioned Medium: Follow-up With Trichograms. Eplasty. 2015; 15:e10. PMC: 4379938. View

Ludwig E . Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977; 97(3):247-54. DOI: 10.1111/j.1365-2133.1977.tb15179.x. View

Kim S, Kye J, Lee M, Park B . Evaluation of mesotherapy as a transdermal drug delivery tool. Skin Res Technol. 2015; 22(2):158-63. DOI: 10.1111/srt.12243. View

Mao Y, Liu P, Wei J, Xie Y, Zheng Q, Li R . Cell Therapy for Androgenetic Alopecia: Elixir or Trick?. Stem Cell Rev Rep. 2023; 19(6):1785-1799. PMC: 10390634. DOI: 10.1007/s12015-023-10532-2. View

Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A . Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. J Eur Acad Dermatol Venereol. 2017; 32(1):11-22. DOI: 10.1111/jdv.14624. View

Evans A, Mwangi J, Pope R, Ivanic M, Botros M, Glassman G . Platelet-rich plasma as a therapy for androgenic alopecia: a systematic review and meta-analysis. J Dermatolog Treat. 2020; 33(1):498-511. DOI: 10.1080/09546634.2020.1770171. View

Paichitrojjana A, Paichitrojjana A . Platelet Rich Plasma and Its Use in Hair Regrowth: A Review. Drug Des Devel Ther. 2022; 16:635-645. PMC: 8922312. DOI: 10.2147/DDDT.S356858. View

10.

Li M, Qu K, Lei Q, Chen M, Bian D . Effectiveness of Platelet-Rich Plasma in the Treatment of Androgenic Alopecia: A Meta-Analysis. Aesthetic Plast Surg. 2023; 48(5):977-984. PMC: 10980625. DOI: 10.1007/s00266-023-03603-9. View

11.

Gupta A, Carviel J . Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia. J Dermatolog Treat. 2016; 28(1):55-58. DOI: 10.1080/09546634.2016.1179712. View

12.

Dhurat R, Sukesh M . Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. J Cutan Aesthet Surg. 2015; 7(4):189-97. PMC: 4338460. DOI: 10.4103/0974-2077.150734. View

13.

NORWOOD O . Male pattern baldness: classification and incidence. South Med J. 1975; 68(11):1359-65. DOI: 10.1097/00007611-197511000-00009. View

14.

Kapoor R, Shome D . Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth - safety and efficacy evaluation in a first-in-man pilot clinical study. J Cosmet Laser Ther. 2018; 20(6):369-379. DOI: 10.1080/14764172.2018.1439965. View

15.

Gajjar P, Mehta H, Barvaliya M, Sonagra B . Comparative Study between Mesotherapy and Topical 5% Minoxidil by Dermoscopic Evaluation for Androgenic Alopecia in Male: A Randomized Controlled Trial. Int J Trichology. 2019; 11(2):58-67. PMC: 6463458. DOI: 10.4103/ijt.ijt_89_18. View

16.

Zhang X, Ji Y, Zhou M, Zhou X, Xie Y, Zeng X . Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Cutan Med Surg. 2023; 27(5):504-508. DOI: 10.1177/12034754231191461. View

17.

Plachouri K, Georgiou S . Mesotherapy: Safety profile and management of complications. J Cosmet Dermatol. 2019; 18(6):1601-1605. DOI: 10.1111/jocd.13115. View

18.

Ince B . Response to Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia. Aesthetic Plast Surg. 2023; 48(15):3014-3015. DOI: 10.1007/s00266-023-03527-4. View

19.

Alves R, Grimalt R . A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disord. 2018; 4(1):18-24. PMC: 5806188. DOI: 10.1159/000477353. View